A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of Humira?? (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD) - CAPE
|Effective start/end date||6/18/15 → 12/31/25|
- ABBVIE INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.